Epigral reports ₹64.42 crore profit for Q2 FY27

Epigral Limited has announced its unaudited financial results for the second quarter and half year ended September 30, 2026. For the quarter, the company reported a profit after tax of ₹64.42 crore. The consolidated revenue for the quarter stood at ₹751.81 crore. The results also indicate a healthy growth in other comprehensive income, contributing to the overall financial performance.

Epigral Announces Q2 FY27 Financial Results

Epigral Limited disclosed its unaudited financial results for the quarter and half year ending September 30, 2026. The Board of Directors reviewed and approved these results, which reflect the company’s performance during the specified periods.

Standalone Financial Highlights

Quarter Ended September 30, 2026:

  • Revenue from operations: ₹745.99 crore
  • Other income: ₹5.82 crore
  • Total income: ₹751.81 crore
  • Total expenses: ₹664.89 crore
  • Profit before tax: ₹86.92 crore
  • Tax expense: ₹22.50 crore
  • Profit after tax: ₹64.42 crore
  • Total Comprehensive Income: ₹64.42 crore

Half Year Ended September 30, 2026:

  • Revenue from operations: ₹1,451.35 crore
  • Other income: ₹9.92 crore
  • Total income: ₹1,461.27 crore
  • Total expenses: ₹1,241.17 crore
  • Profit before tax: ₹220.10 crore
  • Tax expense: ₹56.50 crore
  • Profit after tax: ₹163.60 crore
  • Total Comprehensive Income: ₹163.61 crore

Consolidated Financial Highlights

Quarter Ended September 30, 2026:

  • Revenue from operations: ₹745.99 crore
  • Other income: ₹5.82 crore
  • Total income: ₹751.81 crore
  • Total expenses: ₹664.89 crore
  • Profit before exceptional items, share of profit/(loss) from Associates and tax: ₹86.92 crore
  • Profit before exceptional items and tax: ₹87.58 crore
  • Tax expense: ₹22.50 crore
  • Profit after tax: ₹65.08 crore
  • Total Comprehensive Income: ₹65.08 crore

Half Year Ended September 30, 2026:

  • Revenue from operations: ₹1,193.90 crore
  • Other income: ₹9.99 crore
  • Total income: ₹1,203.89 crore
  • Total expenses: ₹1,027.21 crore
  • Profit before exceptional items, share of profit/(loss) from Associates and tax: ₹176.68 crore
  • Profit before exceptional items and tax: ₹176.66 crore
  • Tax expense: ₹35.25 crore
  • Profit after tax: ₹211.91 crore
  • Total Comprehensive Income: ₹211.67 crore

The company also provided its Balance Sheet and Cash Flow statements for the respective periods. The review report from SRBC & CO LLP, Chartered Accountants, confirms that the financial results have been prepared in accordance with the applicable accounting standards.

Source: BSE

Previous Article

Eureka Forbes reports Q2 FY27 unaudited financial results

Next Article

Epigral Limited reports 26% PAT growth in Q2 FY27